What is the impact of anemia pharmacotherapy on chronic kidney disease progression?

被引：0
|
作者：
Webb, Hanna T. [1 ]
Wish, Jay B. [1 ]
机构：
[1] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2024年 / 25卷 / 10期
关键词：
Anemia; chronic kidney disease; erythropoietin; hypoxia-inducible factor; SGLT2-inhibotors; CHRONIC-RENAL-FAILURE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; THERAPY; DECLINE; ALPHA;
D O I：
10.1080/14656566.2024.2384560
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1265 / 1269
页数：5
相关论文
共 50 条
  • [41] Anemia and the heart in chronic kidney disease
    Zalunardo, Nadia
    Levin, Adeera
    SEMINARS IN NEPHROLOGY, 2006, 26 (04) : 290 - 295
  • [42] Halting the Progression of Chronic Kidney Disease: Experiences with Long Term Total Correction of Anemia
    von Hartitzsch, Barry
    Udupa, A. Deviprakash
    Bourdeau, James E.
    Fu, Jay
    Gold, Robert M.
    BLOOD PURIFICATION, 2010, 30 (03) : 221 - 221
  • [43] Impact of anemia on hospitalization and mortality in elderly patients with chronic obstructive pulmonary disease and chronic kidney disease
    Coley, KC
    Saul, MI
    Kirisci, L
    Smith, RB
    VALUE IN HEALTH, 2004, 7 (03) : 256 - 256
  • [44] Prevalence, impact and progression of peripheral neuropathy in early chronic kidney disease
    Arnold, Ria
    Issar, Tushar
    Kwai, Natalie
    Pussell, Bruce
    Poynten, Ann
    Krishnan, Arun
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 382 - 382
  • [45] Serum bilirubin level and its impact on the progression of chronic kidney disease
    Uludag, Koray
    Oguzhan, Nilufer
    Arikan, Tamer
    Boz, Gulsah
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (09) : 1695 - 1701
  • [46] Serum bilirubin level and its impact on the progression of chronic kidney disease
    Koray Uludag
    Nilufer Oguzhan
    Tamer Arıkan
    Gulsah Boz
    International Urology and Nephrology, 2018, 50 : 1695 - 1701
  • [47] Interaction of anemia and chronic kidney disease stage in the progression of the disease in children - The SP-CKDKids study
    Nogueira, Paulo Koch
    Andrade, Olberes Vitor
    Gago, Paloma
    Sanches, Mariana Tomaz
    Belangero, Vera
    Do Val, Maria Luiza
    Gabriele, Marina
    Machado, Ivan
    Nussenzveig, Paula
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2362 - 2363
  • [48] PREVALENCE OF ANEMIA IN EARLY STAGE OF DIABETIC NEPHROPATHY (CHRONIC KIDNEY DISEASE STAGE II) AND ITS IMPACT ON THE PROGRESSION OF RENAL FUNCTION
    Gjata, M.
    Nelaj, E.
    Sadiku, E.
    Collaku, E.
    Tase, M.
    JOURNAL OF HYPERTENSION, 2010, 28 : E288 - E288
  • [49] Pharmacotherapy of chronic kidney disease and mineral bone disorder
    Barreto, Fellype Carvalho
    de Oliveira, Rodrigo Azevedo
    Oliveira, Rodrigo Bueno
    Jorgetti, Vanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2627 - 2640
  • [50] Pharmacotherapy in patients suffering from chronic kidney disease
    Kielstein, J. T.
    Keller, F.
    INTERNIST, 2012, 53 (07): : 802 - +
12345